• Lariago


  • Chloroquine phosphate
  • Resochin
  • 250 mg, 500 mg
  • IPCA

Treatment of acute attacks of malaria due to P. vivax, P. malariae, P. ovale, and susceptible strains of P. falciparum.

Chemoprophylaxis in non-immune individuals at risk.

Chloroquine does not prevent relapses in patients with vivax or malariae malaria because it is not effective against exoerythrocytic forms of the parasite.

The drug is also indicated for the treatment of extraintestinal amebiasis.

Lariago 250mg - Box contains 25 Strips of Ten Tablets
Lariago DS 500 mg - Box contains 20 Strips of Five Tablets